Abstract:OBJECTIVE:To investigate the effect of the sciatic nerve elongation on pain in rats. METHODS:Thirty-six adult male Wistar rats of SPF grade, weighing 250-300 g. Eighteen of them were randomly divided into 3 groups, 6 rats in each group. They were sciatic nerve elongation group (group A), nerve no-elongation group (group B), and nerve ligation group (group C). The model of 10-mm sciatic nerve defect was established in all 3 groups. The sciatic nerve was extended at a speed of 1 mm/d for 14 days in group A. The group B was only installed with external fixation. The nerve stumps were ligated in the group C. At 3, 7, 10, and 14 days after operation, the foot injury was evaluated by the autotomy scoring scale. At 14 days after operation, the dorsal root ganglia (DRG) of L 4-S 1 spinal cord of rats in each group was observed by tumor necrosis factor α (TNF-α) immunohistochemical staining, and the primary antibodies were replaced by pure serum as negative control group. Another 18 rats were randomly divided into 3 groups, 6 rats in each group. They were sciatic nerve elongation group (group A1), nerve no-elongation group (group B1), positive control group (group C1). In groups A1 and B1, the 10-mm long sciatic nerve defect model was established by the same method as groups A and B, and then fixed with external fixation. Nerve elongation was done or not done without anesthesia at 3 days after operation. In group C1, no modeling was done and 20 μL 2.5% formaldehyde was injected into the toes. After 90 minutes, the dorsal horn of spinal cord of L 4-S 1 segment of rats was cutting for c-Fos immunohistochemical staining and the number of positive cells was counted. Primary antibodies were replaced with pure serum as negative control group. RESULTS:The autotomy scores of rats in groups B and C gradually increased postoperatively, and group A remained stable at 0.25±0.50. The scores of group C were significantly higher than those of group A and group B at each time point postoperatively ( P<0.05). The scores of group A were significantly lower than those of group B at 10 and 14 days postoperatively ( P<0.05). TNF-α immunohistochemical staining showed that the TNF-α expression in group A was weak, slightly positive (+/-); in group B was positive (+); in group C was strongly positive (++); and the negative control group had no TNF-α expression (-). c-Fos immunohistochemical staining showed that the c-Fos expressions in groups A1 and B1 were weak positive, in group C1 was strong positive, and negative control group had no c-Fos positive expression. The number of c-Fos positive cells in groups A1, B1, C1, and negative control group were (21.5±6.6), (19.3±8.1), (95.6±7.4), and 0 cells/field, respectively, and group C1 was significantly higher than groups A1 and B1 ( P<0.05), there was no significant difference between group A1 and group B1 ( P>0.05). CONCLUSION:Nerve elongation does not cause obvious pain neither during the operation of elongation nor throughout the whole elongation.

Effects of Akt1 Gene Knockout on Pain Behaviour Induced by Chronic Constriction Injury of Sciatic Nerve in Mice

Effects of Akt3 gene knockout on pain behaviors induced by chronic constriction injury of sciatic nerve in mice

Mechanisms of Akt3 gene knockout on neuropathic pain in mice with sciatic nerve ligation

Role of Akt/GSK-3β Signaling Pathway in Neuropathic Pain in Mice

Effects of Ghrelin on Pgsk-3Β and Β-Catenin Expression when Protects Against Neuropathic Pain Behavior in Rats Challenged with Chronic Constriction Injury

Effect of sciatic nerve pulsed radiofrequency glial activation levels in spinal dorsal horn in chronic constriction injury rat models and its analgesia effect

Effects of Intrathecally CREB Antisense Oligodeoxynucleotide on Pain Behaviors in a Mouse Model of Chronic Constriction Injury of Sciatic Nerve

Effects of intrathecal injection of Akt inhibitor Ⅳ on pain behavior in rats model of injected radicular pain

Effect and Mechanism of Inhibition of PI3K/Akt/mTOR Signal Pathway on Chronic Neuropathic Pain and Spinal Microglia in a Rat Model of Chronic Constriction Injury.

The Analgesic Effects of (5R,6R)6-(3-Propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1] Octane on a Mouse Model of Neuropathic Pain.

Effects of varying degrees of ligation in a neuropathic pain model induced by chronic constriction injury

Delayed Inhibition of ERK and P38 Attenuates Neuropathic Pain Without Affecting Motor Function Recovery after Peripheral Nerve Injury.

Effects of Akt inhibitor Ⅳ on prevention and treatment the hyperalgesia induced by remifentanil

Antinociceptive and anti-inflammatory effects of cryptotanshinone through PI3K/Akt signaling pathway in a rat model of neuropathic pain

Effect of intrathecal different dose of kinesin superfamily 17 on the development of bone cancer pain in mice

Long Non-Coding RNA CCAT1 Modulates Neuropathic Pain Progression Through Sponging Mir-155

Effects of Repeated Intrathecally KIF17 Antisense Oligodeoxynucleotide on the Expression of Mlin10 and NR2B in Spinal Cord in a Mouse Model of Bone Cancer Pain

Effects of Intrathecal Injection of Different Dose of Protein Kinase B Inhibitor IV on Hyperalgesia Induced by Remifentanil

Exploring the Pain Attenuating Potential of Imatinib in Chronic Constriction Injury Model of Neuropathic Pain

[Experimental study of the effect of the sciatic nerve elongation on pain in rats].

Alterations in mouse spinal cord and sciatic nerve microRNAs after the chronic constriction injury (CCI) model of neuropathic pain